Agile Therapeutics Inc (AGRX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Agile Therapeutics Inc (AGRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7988
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its pipeline product candidate include AG200-15, a once-weekly prescription contraceptive patch designed using its skinfusion technology to deliver both hormones over a seven-day period. The company’s other hormonal contraceptive pipeline include AG200-SP, a novel regimen designed to allow women to experience shorter, lighter periods; AG200-ER, an extended cycle regimen that allows a woman to extend the time between her episodes of withdrawal bleeding. Agile is headquartered in Princeton, New Jersey, the US.

Agile Therapeutics Inc (AGRX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Agile Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Agile Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Agile Therapeutics Secures USD25 Million from Hercules 11
Agile Therapeutics Raises USD3 Million in Venture Financing 13
Agile Therapeutics Raises US$40 Million In Series C Financing 14
Equity Offering 16
Agile Therapeutics Prices Public Offering of Shares for USD20 Million 16
Agile Therapeutics Raises USD40.3 Million in Public Offering of Shares 18
Agile Therapeutics Raises USD20 Million in Private Placement of Shares 20
Agile Therapeutics Raises USD55 Million in IPO 22
Agile Therapeutics Inc – Key Competitors 24
Agile Therapeutics Inc – Key Employees 25
Agile Therapeutics Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 03, 2018: Agile Therapeutics reports second quarter 2018 financial results 27
May 07, 2018: Agile Therapeutics Announces First Quarter 2018 Financial Results 29
Mar 12, 2018: Agile Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results 30
Nov 06, 2017: Agile Therapeutics Reports Third Quarter 2017 Financial Results 31
Jul 28, 2017: Agile Therapeutics Reports Second Quarter 2017 Financial Results 33
May 08, 2017: Agile Therapeutics Reports First Quarter 2017 Financial Results 35
Mar 08, 2017: Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results 37
Other Significant Developments 39
Jun 07, 2018: Agile Therapeutics Provides Corporate Update and Revised Cash Guidance 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Agile Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Agile Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Agile Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Agile Therapeutics Secures USD25 Million from Hercules 11
Agile Therapeutics Raises USD3 Million in Venture Financing 13
Agile Therapeutics Raises US$40 Million In Series C Financing 14
Agile Therapeutics Prices Public Offering of Shares for USD20 Million 16
Agile Therapeutics Raises USD40.3 Million in Public Offering of Shares 18
Agile Therapeutics Raises USD20 Million in Private Placement of Shares 20
Agile Therapeutics Raises USD55 Million in IPO 22
Agile Therapeutics Inc, Key Competitors 24
Agile Therapeutics Inc, Key Employees 25

List of Figures
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Agile Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Agile Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Agile Therapeutics Inc (AGRX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Editas Medicine Inc (EDIT):企業の財務・戦略的SWOT分析
    Editas Medicine Inc (EDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Oxurion NV (THR):製薬・医療:M&Aディール及び事業提携情報
    Summary Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreo …
  • New Enterprise Associates Inc:企業のM&A・事業提携・投資動向
    New Enterprise Associates Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New Enterprise Associates Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Attijariwafa Bank SA (ATW):企業の財務・戦略的SWOT分析
    Attijariwafa Bank SA (ATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ameren Corp (AEE):企業の財務・戦略的SWOT分析
    Ameren Corp (AEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • comdirect bank AG:企業の戦略・SWOT・財務情報
    comdirect bank AG - Strategy, SWOT and Corporate Finance Report Summary comdirect bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tanzania Electric Supply Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Tanzania Electric Supply Co Ltd (TANESCO), formerly Tanganyika Electric Supply Company Limited, is a government-owned integrated power company. The company’s operations are regulated by the Ministry of Energy and Minerals. It generates, transmits, distributes and supplies electricity. TANESC …
  • Adhera Therapeutics (MRNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Adhera Therapeutics (Adhera) is a nucleic acid-based drug discovery and development company that focuses on rare diseases. It focuses on treating the intersection of arthritis, hypertension, pain, and cancer using combination therapies of already approved drugs. The company is developing and …
  • Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comp …
  • InspireMD Inc (NSPR)-医療機器分野:企業M&A・提携分析
    Summary InspireMD Inc (InspireMD), formerly Saguaro Resources Inc is a medical device company that develops and commercializes stent platform MGuard technology. The company’s products include carotid embolic prevention system, Mguard embolic prevention system and Mguard prime. Its MGuard is based on …
  • Verax Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Verax Biomedical Inc (Verax) is a developer of rapid tests for the detection of bacterial contaminants in tissues for transplantation, blood components, and cellular therapies. The company’s products include platelet pgd test, red cell pgd test and cell therapy PGD test. It uses the PGD tech …
  • PTT Public Co Ltd (PTT):石油・ガス:M&Aディール及び事業提携情報
    Summary PTT Public Co Ltd (PTT) is a state-owned integrated national oil and gas, and petrochemical company. It operates in oil and natural gas, coal, power, and infrastructure businesses. The company carries out oil and natural gas exploration and production; oil refining; procurement, processing, …
  • Range Resources Corporation:企業の戦略・SWOT・財務情報
    Range Resources Corporation - Strategy, SWOT and Corporate Finance Report Summary Range Resources Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Petrofac Ltd (PFC):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrofac Limited (Petrofac) is an oilfield services company that provides integrated services to production and processing industries. It designs and builds oil and gas facilities; operates, maintains and manages facilities on behalf of its customers and trains personnel. It also develops an …
  • LaSalle Hotel Properties:企業のM&A・事業提携・投資動向
    LaSalle Hotel Properties - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LaSalle Hotel Properties Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Zecotek Photonics Inc (ZMS):医療機器:M&Aディール及び事業提携情報
    Summary Zecotek Photonics Inc. (Zecotek) is a photonics technology company that focuses on developing advanced materials and integrated optoelectronic devices for optical precision surgery, high resolution medical imaging and biopharmaceutical research. It develops and sells scintillation crystals, …
  • New Image Group Ltd:企業の戦略的SWOT分析
    New Image Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Canaan Partners:企業のM&A・事業提携・投資動向
    Canaan Partners - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Canaan Partners Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Spritzer Bhd:企業の戦略・SWOT・財務分析
    Spritzer Bhd - Strategy, SWOT and Corporate Finance Report Summary Spritzer Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Central Securities Corp (CET):企業の財務・戦略的SWOT分析
    Summary Central Securities Corp (Central Securities) is a financial service provider that provides investment services. The company offers investment management services and stock investment related services. It invests on convertible preferred stocks, bonds, preferred stocks, convertible bonds, war …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆